-
1
6.7% of active clinical trials disrupted by Middle East conflict.
-
2
Phase 3 trials are most affected, with significant patient populations.
-
3
Major impacts noted in Turkey, Israel, Egypt, and surrounding regions.
-
4
Focus on oncology trials, especially breast and lung cancer.
-
5
Emphasizes need for a data-driven approach to adapt trial strategies.
-
6
Importance of maintaining patient safety and data integrity.
-
7
Potential use of external control arms and digital twin strategies.
Original Source(s)
Related Content
Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds
Combining a visual inspection of the bladder—systematic endoscopic evaluation—with a blood test to check for the presence of ctDNA may accurately predict which patients with bladder cancer still have ...
April 10, 2026
-
3 min
Frontline Pharma: Tao Chen
A new series championing scientists in the pharmaceutical industry begins with Genentech’s rising star
April 10, 2026
-
8 min
How AI Is Already Having a Significant Impact on Cancer Care
Three education sessions presented during the 2025 ASCO Annual Meeting showcased how artificial intelligence (AI) is quickly transforming cancer care from clinical trial planning and ambient scribes t...
by Jo Cavallo
April 10, 2026
-
10 min
